摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

TpsT | 200335-37-1

中文名称
——
中文别名
——
英文名称
TpsT
英文别名
1-[(2R,4S,5R)-4-hydroxy-5-[[hydroxy-[(2R,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-sulfidophosphaniumyl]oxymethyl]oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-olate
TpsT化学式
CAS
200335-37-1
化学式
C20H26N4O11PS
mdl
——
分子量
561.486
InChiKey
BAYJGGZTPVYYDX-GOBUZWBYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.5
  • 重原子数:
    37
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    231
  • 氢给体数:
    4
  • 氢受体数:
    12

反应信息

点击查看最新优质反应信息

文献信息

  • Thermolytic 4-Methylthio-1-butyl Group for Phosphate/Thiophosphate Protection in Solid-Phase Synthesis of DNA Oligonucleotides
    作者:Jacek Cieślak、Andrzej Grajkowski、Victor Livengood、Serge L. Beaucage
    DOI:10.1021/jo035861f
    日期:2004.4.1
    phosphate/thiophosphate protecting group for DNA oligonucleotides has been investigated for its potential application to a “heat-driven” process for either oligonucleotide synthesis on diagnostic microarrays or, oppositely, to the large-scale preparation of therapeutic oligonucleotides. The preparation of phosphoramidites 10a−d is straightforward, and the incorporation of these amidites into oligonucleotides via solid-phase
    已经研究了用于DNA寡核苷酸的不耐热的4-甲基硫基-1-丁基磷酸酯/硫代磷酸酯保护基团,其在诊断芯片上合成寡核苷酸的“热驱动”过程中具有潜在的应用潜力,或者相反,在大规模制备寡核苷酸时具有潜在的应用价值。治疗性寡核苷酸。亚磷酰胺10a - d的制备这是很简单的,并且通过固相技术将这些亚酰胺掺入寡核苷酸的过程与使用2-氰基乙基脱氧核糖核苷亚磷酰胺所实现的过程一样有效。4-甲基硫基-1-丁基磷酸酯/硫代磷酸酯保护基的多功能性可通过在中性条件下于55°C在中性条件下于55°C的水性缓冲液中加热30分钟或在55°C的浓缩条件下2小时内从寡核苷酸中轻松去除而获得。 NH 4 OH。脱保护反应通过分子内环脱酯化机理发生,导致形成salt盐18。与脱氧核糖核苷和N混合时在近似于大规模(> 50 mmol)寡核苷酸脱保护反应的条件下,在保护的2'-脱氧核糖核苷或模型硫代磷酸酯二酯的作用下,盐18不会显着改
  • Synthesis of dinucleoside phosphates and their analogs by the boranophosphotriester method using azido-based protecting groups
    作者:Toshihide Kawanaka、Mamoru Shimizu、Takeshi Wada
    DOI:10.1016/j.tetlet.2007.01.064
    日期:2007.3
    backbone-modified analogs were synthesized in good yields by the boranophosphotriester method in solution. The oligodeoxyriobonucleoside boranophosphates, fully protected with 2-(azidomethyl)benzoyl groups, were converted to the various backbone-modified DNA analogs via the corresponding H-phosphonate intermediates. A new efficient protecting group for the O6-position of 2′-deoxyguanosine, 4-[(2-azidom
    通过硼三磷酸硼酸酯方法在溶液中以高收率合成了寡脱氧核糖核苷酸及其骨架修饰的类似物。用2-(叠氮基甲基)苯甲酰基充分保护的寡脱氧核糖核苷硼酸磷酸酯通过相应的H-膦酸酯中间体转化为各种骨架修饰的DNA类似物。还开发了一种新的2'-脱氧鸟苷的O 6位有效保护基,即4-[((2-叠氮基甲基)苯甲酰氧基]苄基(AZBn)。发现通过在二恶烷–2-巯基乙醇–H 2 O中用MePPh 2处理可以快速去除AZBn组。
  • Kinetic and Theoretical Studies on the Mechanism of Alkaline Hydrolysis of DNA
    作者:Naoya Takeda、Masahiko Shibata、Nobuo Tajima、Kimihiko Hirao、Makoto Komiyama
    DOI:10.1021/jo000323d
    日期:2000.7.1
    hydrolysis of thymidine 3'-monophosphate esters (including thymidylyl(3'-5')thymidine (Tp-OT)) monotonically decrease as the leaving groups get poorer. According to the theoretical calculation in which the solvent effects are incorporated, no intermediate is formed in the course of the reaction. In the alkaline hydrolysis of the activated Tp-OT analogues having good leaving groups, the 3',5'-cyclic monophosphate
    通过动力学分析和密度泛函理论计算研究了碱水解DNA的反应机理。胸苷3'-单磷酸酯(包括胸苷基(3'-5')胸苷(Tp-OT))的水解速率随着离去基团的变差而单调降低。根据结合了溶剂作用的理论计算,在反应过程中没有形成中间体。在具有良好离去基团的活化的Tp-OT类似物的碱性水解中,通过5'-烷氧基离子通过分子内攻击同时形成了胸苷的3',5'-环单磷酸。但是,在天然二核苷酸的水解中,不会发生这种副反应,因为由于构象约束而不能形成导致其贫穷的离开群体离开的过渡状态。对磷酸二甲酯及其O(桥基)-> S取代类似物水解的理论分析支持了这些观点。
  • Allyl Group as a Protecting Group for Internucleotide Phosphate and Thiophosphate Linkages in Oligonucleotide Synthesis:  Facile Oxidation and Deprotection Conditions
    作者:Muthiah Manoharan、Yixin Lu、Martin D. Casper、George Just
    DOI:10.1021/ol9910518
    日期:2000.2.1
    [reaction: see text] The allyl group, which serves as a protecting group for an internucleotide bond for both phosphates and phosphorothioates, can be easily removed by good nucleophiles under weakly basic or neutral conditions. For a practical synthesis on solid support, camphorsulfonyloxaziridine was used as the oxidizing agent for synthesizing DNA, while the Beaucage reagent was used for preparing
    [反应:见正文]烯丙基是弱磷酸盐或硫代磷酸酯的核苷酸间键的保护基,很容易在弱碱性或中性条件下被良好的亲核试剂除去。对于在固体载体上的实际合成,将樟脑磺酰基恶二丙啶用作合成DNA的氧化剂,而Beaucage试剂用于制备硫代磷酸酯低聚物。两种类型的寡核苷酸都容易通过含有2%巯基乙醇的浓氢氧化铵去保护。
  • Assessment of heat-sensitive thiophosphate protecting groups in the development of thermolytic DNA oligonucleotide prodrugs
    作者:Cristina Ausín、Jon S. Kauffman、Robert J. Duff、Shankaramma Shivaprasad、Serge L. Beaucage
    DOI:10.1016/j.tet.2009.10.096
    日期:2010.1
    Heat-sensitive thiophosphate protecting groups derived from the alcohol 4 or 10 have provided insights in the design of DNA oligonucleotide prodrugs. Indeed, functional groups stemming from the alcohol 9, 15, 16 or 22 may be applicable to thiophosphate protection of immunostimulatory CpG DNA motifs, whereas those originating from the alcohol 3, 5,12,13,18, 20 or 22 offer adequate protection of terminal phosphodiester functions against ubiquitous exonucleases that may be found in biological environments. Functional groups derived from the alcohol 9, 15, 16, 19 or 23 are suitable for the protection of phosphodiester functions flanking the CpG motifs of immunomodulatory DNA sequences. Published by Elsevier Ltd.
查看更多

同类化合物

鸟苷酰-(3'-5')-尿苷 鸟苷酰(3'-5')尿苷3'-单磷酸酯 腺苷酰基-(3,’5’)-胞苷 腺苷酰-(3'→5')-胞苷 腺苷酰-(3'-5')-尿苷3'-单磷酸酯 腺苷基3'-5'-腺苷铵盐 脱氧鸟苷酰-(3'-5')-脱氧腺苷 脱氧腺苷酰-(3'-5')-脱氧鸟苷 脱氧胞苷酰-(3'-5')-脱氧鸟苷 胸苷酰(3'->5')胸苷铵盐 胸苷基(3'5')-2'-脱氧腺苷铵盐 胞苷酰-(5'->3')-鸟苷 胞苷酰-(3',5')-鸟苷 胞苷酰(3'->5')尿苷铵盐 聚(2-氨基脱氧腺嘌呤基-5-碘脱氧尿苷酸) 聚(2-氨基脱氧腺嘌呤基-5-溴脱氧尿苷酸) 环二腺苷酸 尿酸氧化酶 尿苷酰基-(3',5')-尿苷 二(3',5')-环二鸟苷酸 乙基3,4,5-三[[(6-重氮基-5,6-二氢-5-羰基-1-萘基)磺基基]氧代]苯酸酯 [5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基][5-(2,4-二氧代嘧啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [5-(6-氨基嘌呤-9-基)-3,4-二羟基-四氢呋喃-2-基]甲基[羟基-[2,3,4-三羟基-5-(7-甲基-2,4,8-三氧代-1H-嘧啶并[4,5-b]喹啉-10-基)戊氧基]磷酰]磷酸氢酯 [5-(4-氨基-2-氧代-嘧啶-1-基)-3,4-二羟基-四氢呋喃-2-基]甲基[5-(4-氨基-2-氧代-嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(6-氨基嘌呤-9-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,5R)-5-(2,4-二氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基 [(2R,3S,5R)-2-(羟基甲基)-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2,4-二氧代嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 8-氯-黄素腺嘌呤二核苷酸 8-巯基-黄素腺嘌呤二核苷酸 5'-O-胸苷酰 3'-O-(2'-脱氧腺苷)硫代磷酸酯 2'-脱氧鸟苷酰-(5'-3')-2'-脱氧-5'-鸟苷酸 2'-脱氧鸟苷酰-(3'-5')-2'-脱氧胞苷 2'-脱氧腺苷酰-(3'-5')-2'-脱氧腺苷 2'-脱氧胞啶基(3'->5')-2'-脱氧鸟苷铵盐 1-(2-脱氧-5-O-磷羧基五呋喃糖基)-5-[(1E)-3-{[5-(2-羰基六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰基]氨基}丙-1-烯-1-基]嘧啶-2,4(1H,3H)-二酮 5'-dCT 2'-deoxyadenylyl-(3',5')-thymidine ammonium salt d(GpT) [(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-yl] [(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-prop-2-ynoxyoxolan-2-yl]methyl hydrogen phosphate pA3'p5'U pG3'p5'U pG3'p5'C cytidylyl-(3'-5')-3'-amino-3'-deoxy-3'-L-phenylalanyl-N6,N6-dimethyladenosine adenylyl-(3',5')-guanosine deoxyadenosyl(5'-3')thymidine phosphate cAIMP N4-palmitoyl-2'-deoxycytidylyl-(3'->5')-5-fluoro-2'-deoxyuridine